Search results
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s Drug
Bloomberg· 3 days agoUS drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 2 days agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
FierceBiotech· 3 days agoThe docs for Eli Lilly’s donanemab advisory committee meeting are in: the FDA has raised concerns...
FDA Reverses Juul Ban. What Comes Next?
InvestorPlace· 2 days agoThe FDA lifted its ban on Juul’s products after conducting additional studies of the products. Also flavoring the FDA’s</ ...
FDA Reviewers Question Patient Selection for Alzheimer's Drug Candidate
MedPage Today· 4 days agoIf approved, donanemab will be the third amyloid-targeted drug to come to market: the first being...
FDA approves Geron’s RYTELO for MDS associated anaemia
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) has granted approval for Geron’s RYTELO (imetelstat) for...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 2 days ago(Reuters) -The U.S. Food and Drug Administration approved the expanded use of GSK's respiratory...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 23 hours agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters via Yahoo News· 3 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers
Investopedia· 3 days agoGeron (GERN) shares skyrocketed over 19% in intraday trading Friday after the Food and Drug...